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Abstract
Background: It is currently unclear whether reductions in adiposity mediate the improvements
in vascular health that occur with aerobic exercise. The purpose of this longitudinal study of 13
healthy women (33 ± 4 years old) was to determine whether 14 weeks of aerobic exercise would
alter functional measures of vascular health, namely resting aortic pulse wave velocity (aPWV, an
index of arterial stiffness), femoral artery diameter (DFA), and femoral artery blood flow (BFFA)
independent of changes in adiposity.
Methods: Aerobic fitness was assessed as VO2peak normalized to fat-free mass, and adiposity
(percent body fat) was determined by dual energy x-ray absorptiometry. Serum concentrations of
proteins associated with risk for cardiovascular disease, including C-reactive protein (CRP), soluble
intercellular adhesion molecule-1 (sICAM-1), and leptin, were also measured. Subjects cycled for
50 minutes, 3 times per week.
Results: Aerobic fitness normalized to fat-free mass increased 6% (P = 0.03) whereas adiposity did
not change. Resting DFA increased 12% (P < 0.001) and resting shear rate decreased 28% (P =
0.007). Aortic PWV, and serum sICAM-1, CRP and leptin did not change with training.
Conclusion: Significant reductions in adiposity were not necessary for aerobic exercise training
to bring about improvements in aerobic fitness and arterial remodeling. Peripheral arterial
remodeling occurred without changes in central arterial stiffness or markers of inflammation.
Background
Low aerobic fitness is a significant and prevalent risk fac-
tor for future cardiovascular disease (CVD) [1,2]. An
increase in aerobic fitness through exercise training
reduces CVD risk [3,4]. In keeping with this concept,
increased fitness has been shown to improve functional
measures of cardiovascular health, such as aortic stiffness
measured using aortic pulse wave velocity (aPWV) [5]. It
also results in femoral arterial remodeling as determined
from Doppler ultrasound imaging of arterial diameter [6-
8]. In addition, elevated resting shear stress in the femoral
artery results from disuse of the lower extremities [9,10].
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Considering that disuse is also associated with increased
CVD (reviewed in [11]), elevated resting shear stress may
also be associated with increased CVD risk.
Elevated adiposity also increases the risk for CVD and has
increased in prevalence over the last several decades [12-
14]. Therefore, reducing the prevalence of obesity is a
major public health initiative. Elevated adiposity is also
associated with low physical activity and weight reduction
typically involves an increase in physical activity. It is not
presently clear whether elevated adiposity is an independ-
ent risk factor for CVD or merely a proxy for low physical
activity, low fitness, and poor diet. Prospective studies
have shown that aerobic fitness reduces the negative effect
of adipose tissue on CVD mortality [15]. Additionally,
weight loss programs have been associated with repetitive
weight loss and weight gain, net increases in weight and
increased CVD mortality [16-18]. This suggests that pro-
grams designed to improve cardiovascular health may do
better to focus on improved aerobic fitness rather than
weight loss.
The circulating concentrations of several proteins that
may originate from, or influence the development of,
atherosclerotic plaques are currently under investigation
as adjuncts to cholesterol/lipoprotein measurements in
assessment of risk for cardiovascular disease. Among
those reported to be independent predictors of cardiovas-
cular disease risk are C-reactive protein (CRP) [19], solu-
ble intercellular adhesion molecule-1 (sICAM-1) [20],
and leptin [21].
Elevated levels of CRP and sICAM-1 have been associated
with CVD [22], as well as with adiposity [23,24]. Adipos-
ity is also associated with elevations in leptin, an adi-
pocyte-derived, 16 kDa hormone/cytokine that influences
energy balance, thermoregulation and reproductive func-
tion [25]. Leptin receptors have been identified on vascu-
lar cells [26], and several in vitro and animal studies have
indicated that leptin may influence atherosclerotic plaque
development (reviewed in [27]). A reduction in these bio-
logical proteins might confer protection against the pro-
gression of atherosclerosis.
Previous studies that have evaluated the interaction
between aerobic fitness and adiposity have commonly
used body mass index (BMI) as an index of adiposity.
BMI is not a measure of the amount of adipose tissue an
individual has and its relationship to adiposity, or per-
cent body fat, may vary considerably between individuals
[28]. Furthermore, without an accurate measure of adi-
posity, maximal oxygen consumption as an index of aer-
obic fitness is compromised. For example, total body
weight is typically used to normalize oxygen consump-
tion. Therefore, increased adiposity will automatically
lower aerobic fitness irrespective of the maximal capacity
of the individual's cardiorespiratory system and muscles
to deliver and utilize oxygen. Dual energy x-ray absorpti-
ometry (DXA) yields accurate estimates of fat-free mass
[29] which can be used to normalize maximal oxygen
consumption and help minimize this limitation [30].
The purpose of this study was to determine whether a 14-
week aerobic exercise program would 1) improve aerobic
fitness without changing adiposity, 2) improve func-
tional measures of vascular health, and 3) reduce serum
concentrations of proteins associated with risk for cardi-
ovascular disease. A secondary purpose was to determine
whether changes in functional measures of vascular
health and serum concentrations of proteins associated
with risk for cardiovascular disease were dependent upon
changes in aerobic fitness.
Methods
Subjects
Thirteen sedentary healthy women (33 ± 4 years old) were
studied on 2 days within a 7-day span, before and after a
14-week cycle training program. Blood samples were
taken and physiological measurements other than cardi-
orespiratory fitness were made during the morning after
an overnight fast before and after the training intervention
for all subjects. Cardiorespiratory fitness was assessed on
a separate day from other measurements. Subjects
abstained from caffeine or alcohol in the 12 hours prior to
physiological measurements. Subjects were screened to
exclude for self-reported cardiovascular disease, neu-
romuscular disease, hypertension, diabetes, and smoking.
All procedures were approved by the Human Assurance
Committee at the Medical College of Georgia and the
Institutional Review Board at The University of Georgia
and conformed to the regulations laid out in the declara-
tion of Helsinki on the use of human subjects in research.
All subjects were instructed as to the procedures involved
in the project and gave written informed consent before
undergoing testing procedures.
Cardiorespiratory fitness
Maximal exercise testing was performed using a friction-
braked Monark cycle ergometer as described previously
[31]. Although maximal oxygen consumption measured
using the stationary cycle is on the order of 10% lower
than that generated from performance of a treadmill
graded exercise test [32], the stationary cycle was used to
avoid the possible effects of larger body sizes on maximal
testing with protocols involving ambulation. The test
began with 4 minutes of cycling without resistance fol-
lowed by an increase of 15 W every minute [31]. Oxygen
consumption was calculated based on measures of pul-
monary ventilation and mixed expired oxygen and carbon
dioxide using the Vmax Spectra (Yorba Linda, CA). Heart
rate (EKG) and blood pressure (auscultation) wereDynamic Medicine 2008, 7:13 http://www.dynamic-med.com/content/7/1/13
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assessed during each stage and subjects provided subjec-
tive ratings of perceived exertion during every other stage
of the test. Peak oxygen consumption (VO2peak) was
taken as the maximal 30-second average and normalized
to fat-free mass [30].
Body composition
Body composition [total bone mineral content (BMC;
kg), fat mass (FM; kg), fat-free soft tissue mass (FFST; kg),
and % body fat] was measured at baseline and follow-up
using DXA (Delphi A; S/N 70467; Hologic Inc., Bedford,
MA). The same technician analyzed all baseline and fol-
low-up scans using Hologic Whole Body Analysis soft-
ware, version 11.2.
Quality assurance for DXA was carried out by daily cali-
bration against the manufacturer's standard phantom
(Hologic anthropomorphic spine phantom, model DPA/
QDR-1; SN 9374). Fat Mass and FFST measures were cali-
brated by concurrently scanning (with each total body
scan) an external three-step soft tissue wedge (Hologic,
Inc) composed of different thickness levels of aluminum
and lucite, calibrated against stearic acid (100% fat) and
water (8.6% fat). Test-retest measurements using DXA in
premenopausal women (n = 10) scanned twice in our lab
during a 7-day period demonstrated CVs for total body
BMC of 1.2% and percent fat of 2.0%.
Laboratory measurements
Blood samples were obtained by venipuncture after a 12-
hour fast to assay for CRP, ICAM-1, and leptin. Serum was
stored in a -70°C freezer for later analysis. Serum CRP,
leptin and ICAM-1 were assayed using ELISAs constructed
with separately-purchased reagents. Primary antibodies
were polyclonal rabbit anti-human C-reactive protein
(A0073, DAKO, Carpintera, CA), monoclonal mouse
anti-human leptin (MAB398, R, & D Systems, Minneapo-
lis, MN), and monoclonal mouse anti-human ICAM-1
(MAB720, R & D Systems). For all assays, capture antibod-
ies were coated on 96-well polystyrene plates (Corning
#3590, Corning, NY). Samples and standards were incu-
bated in duplicate in plates overnight at 4°C. Detection
limits, inter- and intra-assay variability's for each assay
were: CRP – 0.3 ng/ml, 12%, 3%; leptin – 0.06 ng/ml, 5%,
2%; ICAM-1 – 0.14 ng/ml, 9%, 6%.
To determine if menstrual status influenced any of the
measured variables, serum estradiol and progesterone
concentrations were measured using ELISA kits from
Diagnostic Systems Labs (Webster, TX). The estradiol
assay (DSL-10-4300) had a sensitivity of 7 pg/ml with
intra- and inter-assay variability's of 5 and 8%, respec-
tively. The progesterone assay (DSL-10-3900) had a sensi-
tivity of 0.13 ng/ml with intra- and inter-assay variability's
of 7 and 5%, respectively.
Aortic pulse wave velocity and arterial blood pressure
Aortic pulse wave velocity was used to evaluate central
arterial stiffness [33] using the Biopac MP100 physiologi-
cal data acquisition system (Biopac Systems Inc., Goleta,
CA) and AcqKnowledge software (v3.7.3). One electrode
was placed over the superior and another over the distal-
most boundary of each scapulae, with a third placed on
the lower back. A 40.6–66.0 cm Biopac blood pressure
cuff (RX120F) was interfaced with a TSD120 transducer
and DA100C general purpose transducer amplifier. All
recordings were made after 30 minutes of supine rest.
Peripheral arterial blood pressure was measured during
this period over the brachial artery of the left arm with a
semi-automated blood pressure machine (Datascope,
Mahwah, NJ) using an appropriate-sized cuff [34]. The
average of 3 to 4 blood pressure readings was used for sub-
sequent analysis.
Distance from the sternal notch to the thigh cuff was
measured with a standard tape measure maintaining a
parallel orientation of the tape measure to the examina-
tion table without conforming to body topography. The
time difference between the inflection point of the systolic
pulse wave and the peak of the R-wave of the EKG signal
was calculated for 30 cardiac cycles for which the pulse
wave inflection point was most distinct. A time constant
of 0.05 sec was subtracted from this difference to correct
for isovolumic contraction phase that precedes ejection
[35]. The calculation was performed as follows: aPWV =
distance (cm) ÷ [time difference (sec) - 0.05 (sec)]. Day-
to-day reproducibility with 2 testing days was evaluated in
17 subjects (11 females, 6 males; 22 ± 2 yrs of age) using
this method of evaluating aPWV with an average day-to-
day difference of 8.1%.
Femoral artery diameter, blood flow, and shear rate
In all tests the subject rested quietly in the supine position
for 15 minutes before data acquisition began. One sonog-
rapher performed all tests for this study. B-mode imaging
was used to visualize the artery 1 – 5 cm distal to the fem-
oral bifurcation using a LogiQ 400CL (General Electric,
Rainbow City, AL) with a 7–13 MHz linear-array ultra-
sound transducer. B-mode images were recorded during
diastole for off-line diameter (mm) measurements. Rest-
ing blood velocity (cm/second) was assessed using pulsed
Doppler ultrasound recorded in the longitudinal view
using an insonation angle between 45° and 60°. The
velocity gate was set to include the entire lumen area.
Time averaged maximum velocity (TAMAX) was auto cal-
culated every cardiac cycle by the GE 400CL advanced vas-
cular program. TAMAX values were acquired and saved
directly to a computer using specially coded optical char-
acter recognition software (NI LabVIEW 6i, Austin, TX),
allowing data acquisition on a beat-by-beat basis. Image
files were opened using semi-automated software spe-
cially coded for use with NI LabVIEW. Arterial diameterDynamic Medicine 2008, 7:13 http://www.dynamic-med.com/content/7/1/13
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was measured manually by applying straight lines con-
forming to the wall-lumen interface of two-dimensional
images captured during data collection. Blood flow (mL/
min) is the product of blood velocity and artery cross-sec-
tional area and was calculated as follows: blood flow =
[π(diameter/2)2]*[velocity*60 seconds/minute]. We used
shear rate as an estimate of shear stress. Shear rate was cal-
culated as blood velocity ÷ diameter [36].
Day-to-day reproducibility for resting diameter, blood
velocity, blood flow, and shear rate was evaluated
between 2 testing days in 15 subjects (9 females, 6 males;
21 ± 1 yrs of age) that were not part of the training study.
Average day-to-day difference for diameter, blood veloc-
ity, blood flow, and shear rate was 1.7%, 30.0%, 32.1%,
and 19.9%, respectively.
Training intervention
The training program was conducted at the University of
Georgia's Adult Fitness Center. Subjects were scheduled to
exercise three times per week for 14 weeks under direct
supervision of one of the study's investigators but were
permitted to conduct exercise sessions on their own on an
infrequent basis in the event of extenuating personal cir-
cumstances. Any subject who utilized this option had to:
1) have access to a stationary cycle, 2) be thoroughly
familiar with the protocol, and 3) be proficient at moni-
toring heart rate while cycling. This was infrequent for 11
of the 13 subjects. Although two subjects conducted 50%
of their exercise sessions away from our direct supervision,
their results were not markedly different from the rest of
the group.
Airdyne bikes were utilized for training with minimal or
no use of handles. Cycling was performed at a comforta-
ble, self-chosen pace during the initial 3–4 sessions of the
training program. After this induction phase, ten 2-
minute alternating intensity bouts (high and low) fol-
lowed the warm-up. Each session included 5 minutes of
warm up, 40 minutes of intermittent intensity cycle train-
ing (2 minutes high, 2 minutes low), and 5 minutes of
cool down, for a total of 50 minutes of pedaling. High
intensities were chosen to elicit a heart rate of 75–90% of
heart rate reserve and were achieved through an increase
in pedaling speed. Low intensities were chosen to elicit
55–65% of heart rate reserve. Heart rate responses were
monitored to ensure that proper intensities were
achieved. Figure 1 illustrates results of one session for one
subject while heart rate and expiratory gases were meas-
ured using EKG and open circuit spirometry. Percent heart
rate reserve and percent VO2 reserve were closely matched
during the training session (r = 0.92), supporting our use
of heart rate to control and monitor training intensity.
Statistical analysis
Statistical analyses were performed with the SPSS (version
13.0) statistical package. Measurements made before and
after training were evaluated using paired Student's t-tests.
Non-normal data were logarithmically transformed and
verified as normal before proceeding with parametric
analysis. Results are reported as mean (SD) unless other-
wise noted and statistical significance was determined at P
≤ 0.05.
Results
The physical characteristics of the subjects are shown in
Table 1. The training program did not result in a change
in body weight or BMI. There was a trend for small
increases in fat-free mass and decreases in fat mass, but
these changes were not statistically significant. Training
Heart rate and oxygen consumption during one training session for one subject Figure 1
Heart rate and oxygen consumption during one training session for one subject. Heart rate and oxygen consump-
tion, as percentages of reserve, changed concurrently throughout the session and both remained above 60% for the entire 40-
minute body of the training session. The upper and lower edge of the box super-imposed on the graph corresponds with 90% 
and 75% of HR reserve, respectively.Dynamic Medicine 2008, 7:13 http://www.dynamic-med.com/content/7/1/13
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resulted in a significant decrease in resting heart rate
(4.6%), although systolic and diastolic arterial blood
pressure did not change.
VO2peak increased 6% with training (44.5 ± 6.8 vs. 47.1 ±
5.7 ml·kgFFM-1·min-1, P = 0.03). In addition, at the high-
est work level of the maximal exercise test that all subjects
were able to perform before and after training (115 W),
there was a decrease in heart rate after training that
approached statistical significance (155 vs 150 bpm, P =
0.07), and a significant reduction in the rate pressure
product (2.5·104  vs 2.2·104  mmHg*bpm, P = 0.02).
These changes are consistent with an improvement in aer-
obic fitness.
Training resulted in a significant increase in femoral artery
diameter from 5.1 ± 0.5 to 5.7 ± 0.5 mm (P < 0.001),
whereas femoral artery blood flow did not change (167 ±
89 vs. 160 ± 68, P = 0.15) (Figure 2). In line with these two
findings, there was a significant decrease in calculated
shear rate from 24.9 ± 9.5 to 17.6 ± 6.1 (P = 0.007). aPWV
did not change with training (886 ± 196 vs. 903 ± 227, P
= 0.30).
No significant changes in CRP, sICAM or leptin were
observed with the training program (Table 2). Leptin val-
ues did correlate with adiposity (r = 0.81 pre, and 0.82
post). No significant differences in serum estradiol or pro-
gesterone were observed in the pre- versus post-training
samples.
Discussion
The key finding of this study was that femoral artery diam-
eter increased with an aerobic training program that
resulted in an increase in fitness without a decrease in adi-
posity in middle aged women. The exercise program used
in this study was similar to commonly used aerobic train-
ing programs in that the exercise intensity was within the
guidelines suggested by the American College of Sports
Medicine [37]. What was slightly different was our use of
varying exercise intensities within each training session in
order to provide variety and to reduce boredom for partic-
ipants. The participants overwhelmingly viewed the train-
ing paradigm favorably and indicated that the program
had achieved this goal. VO2peak values increased 10%
when normalized to body weight. When normalized to
lean tissue, the increase in VO2peak was 6%, which is
slightly less than reported in a comparable study that also
normalized VO2peak to lean body mass [38]. This may be
due to a shorter training program in the present study, as
well as subtle differences in the composition of exercise
sessions between the two studies. We had similar rates of
adherence to the training program. The improvements in
aerobic fitness, in combination with the reduction in rate-
pressure product during maximal exercise testing, suggest
a significant overall physiological adaptation.
The training program implemented in this study resulted
in femoral artery remodeling that was independent of adi-
posity. Physical activity [6,39] and aerobic fitness [40]
have previously been found to be associated with larger
femoral artery diameters. Although previous studies have
found that aging and/or long-term atherosclerotic plaque
accumulation also result in increased artery size as well as
central arterial stiffness [41], the current study evaluated
subjects over a period of only 16 weeks and the study pop-
ulation was homogeneous in age and free of cardiovascu-
lar disease. Our findings of increased aerobic fitness and
decreased heart rate also suggest that sympathetic drive
was reduced. One might expect that a reduction in sympa-
thetic outflow to the legs would result in increased dila-
tion and consequently an increase in artery diameter.
However, previous data suggest that endurance-training
results in either no or slightly elevated sympathetic drive
to the leg at rest [42], which would have resulted in an
opposite change in diameter. Therefore, it is more likely
that the increase in femoral artery diameter found in this
cohort is a sign of remodeling than of arterial deteriora-
tion or increased dilation.
The increase in arterial diameter was associated with a
decrease in resting femoral artery shear rate. Low resting
shear rates represent a positive adaptation to exercise
training as elevated shear rates during exercise induce the
positive arterial adaptations [43-45]. These adaptations
result in larger arteries that subsequently have reduced
shear rates at rest. Adults with spinal cord injury are una-
ble to increase shear rates in their affected limbs and sub-
sequently have smaller arteries and elevated resting shear
rates compared to able-bodied control groups [9,10]. This
suggests that increased resting shear rate is at least associ-
ated with vascular deterioration since spinal cord injury
also results in accelerated CVD progression [46]. There-
Table 1: Physical characteristics before and after training.
Pre
Mean (SD)
Post
Mean (SD)
P-value
Age (yr) 33 (4) --- ---
Height (cm) 160 (6) --- ---
Weight (kg) 74.4 (21.6) 74.3 (21.4) 0.43
BMI (kg/m2) 29.1 (9.1) 29.1 (9.0) 0.38
Body fat (%) 37.3 (7.3) 36.5 (7.0) 0.08
Fat mass (kg) 29.0 (13.8) 28.3 (13.8) 0.12
Fat-free mass (kg) 45.4 (8.4) 46.0 (8.2) 0.08
Heart Rate (bpm) 65 (9) 62 (9) 0.01
Systolic BP (mmHg) 110 (9) 108 (11) 0.14
Diastolic BP (mmHg) 70 (7) 68 (7) 0.10
Data in Pre and Post columns are shown as mean (SD).
P-values were calculated based on paired Student's t-tests.Dynamic Medicine 2008, 7:13 http://www.dynamic-med.com/content/7/1/13
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fore, our results can be cautiously interpreted to suggest
that the training program improved vascular health of the
study participants.
Exercise training did not decrease arterial stiffness (i.e.,
aPWV) in this study. Although cross-sectional studies sug-
gest that higher fitness is associated with lower aPWV, age
may help explain our results. Aortic PWV was found to
increase with age in a group of 480 Chinese citizens (ages
3 to 89) in whom atherosclerosis is known to be rare and
who did not have CVD [47]. Also, cross-sectional studies
of endurance trained older adults do not find the age-
related increases in aPWV found in sedentary older adults
[48,49]. These data suggest that age is a significant and
independent predictor of central arterial stiffness and that
its effects are lessened when accompanied by years of aer-
obic exercise. Therefore, central arterial stiffness may have
not been sufficiently elevated in this study for exercise and
increased fitness to evoke a measurable reduction in this
study. Alternatively, the morphological aspects of the
aorta that aPWV reflects, namely atherosclerotic plaque
accumulation, loss of elastin, and collagen build-up, may
not be significantly reversible in the time frame of this
study [50].
Aerobic training did not reduce serum sICAM-1 concen-
trations. This result was contrary to our hypothesis that
training-induced reductions in shear stress would reduce
sICAM-1 levels. This prediction was based on evidence
that shear stress increases ICAM-1 expression and release
of sICAM-1 from isolated human saphenous vein
endothelial cells [51]. However other factors, including
paracrine influences of IL-1β and TNFα can also increase
ICAM-1 expression and shedding by endothelial cells
[52]. A year-long study of weight reduction through exer-
cise and diet reported a significant 26% reduction in
serum ICAM-1 [24], whereas a 12-week aerobic training
program with weight maintenance reported no changes in
serum ICAM-1 [53].
Aerobic training did not affect serum CRP concentrations.
In fact, the intrasubject coefficient of variability in the
present study (36%) was less than that reported in other
studies which had no intervention of any kind (42–61%,
reviewed in [54]). A previous study reported reductions in
serum CRP in middle-aged women after a 2-year weight
loss program that coupled reduced caloric intake with
increased physical activity [55]. In contrast, serum CRP
did not change in 9–15 year old girls after a 12-week aer-
obic training program involving a weight-maintaining
diet [53]. Other studies have found a positive relationship
between CRP and adiposity [24,56]. Taken together, these
studies indicate that CRP covaries with adiposity, but not
aerobic fitness.
Consistent with previous studies [57,58], we also found
that leptin levels correlated with adiposity. While one
study involving a very low energy diet and weight loss
detected an independent effect of exercise training on lep-
tin concentrations by partial regression analysis [58], our
results were in agreement with a study reporting that exer-
Table 2: Serum proteins associated with CVD, before and after training.
Pre
Median (interquartile range) or Mean (SD)
Post
Median (interquartile range) or Mean (SD)
P-value
CRP (mg/L) † 2.07 (0.86, 3.07) 1.77 (0.38, 2.46) 0.18
sICAM-1 (ng/mL) 169 (37) 172 (74) 0.40
Leptin (ng/mL) 30.7 (22) 26.8 (20) 0.07
† Mean (interquartile range) for the CRP data and Mean ± SD for the other data.
P-values were calculated based on paired Student's t-tests.
aPWV (A) did not change with training Figure 2
aPWV (A) did not change with training. Femoral artery 
diameter (B) increased 12%, femoral artery blood flow (C) 
did not change, and femoral artery shear rate (D) decreased 
29% with training. Data are illustrated as mean ± 95% C.I.Dynamic Medicine 2008, 7:13 http://www.dynamic-med.com/content/7/1/13
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cise without fat loss has little effect on leptin [57]. We
found no evidence that exercise training and increased
aerobic fitness lowered leptin concentrations independ-
ent of adiposity.
This study had some limitations that may limit interpreta-
tion of the results. For example, a potential criticism is the
lack of a control group. Traditional cross-sectional studies
use both experimental and control groups to examine the
effect of the intervention or exposure. However, this study
used a longitudinal, repeated measures design where the
pre-treatment measures from the experimental group
serve as the control. In the repeated measures design all
the participants serve as their own control because they
are involved in the experimental and control groups. We
did not employ a time-matched control group that had
measurements taken twelve weeks apart. Instead, each
subject's pre-treatment data served as control data since
the pre and post data represent measures of the same
physiological variable, except without a preceding train-
ing period. This design is ideal when a limited number of
participants are available because it increases the statisti-
cal power relative to sample size, and therefore the effi-
ciency and sensitivity of the experiment [59,60]. In
addition, we tested a small cohort without signs of cardi-
ovascular disease. Therefore, we feel that the limitations of
this study potentially result from the ability to generalize
to diseased populations rather than from the lack of a con-
trol group. Although the results of this study should be
interpreted with caution, it has provided salient findings
using precise measurements that will assist in the design
of future studies that are larger in breadth.
Conclusion
In conclusion, this study found that 14 weeks of aerobic
exercise increased aerobic fitness and favorably altered
resting femoral artery diameter and shear rate in middle-
aged women without changing adiposity. Future studies
seeking to exercise-train sedentary populations may do
well to use variable intensity programs to increase sub-
jects' interest and potentially increase adherence and
retention. The interpretations of this study are inherently
limited because long-term follow-up would be required to
ultimately determine how these findings relate to progres-
sion of CVD. However, these results suggest that aerobic
training positively influences functional measures of arte-
rial health without a concomitant loss of body fat but that
circulating levels of biological proteins associated with
CVD risk may be more strongly linked to adiposity than
to fitness and/or require longer exercise interventions.
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